LOXO
Vanguard Group’s Loxo Oncology, Inc LOXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-2,789,978
| Closed | -$391M | – | 4155 |
|
|
2018
Q4 | $391M | Buy |
2,789,978
+119,955
| +4% | +$16.8M | 0.02% | 831 |
|
|
2018
Q3 | $456M | Buy |
2,670,023
+281,635
| +12% | +$48.1M | 0.02% | 839 |
|
|
2018
Q2 | $414M | Buy |
2,388,388
+274,225
| +13% | +$47.6M | 0.02% | 878 |
|
|
2018
Q1 | $244M | Buy |
2,114,163
+141,244
| +7% | +$16.3M | 0.01% | 1158 |
|
|
2017
Q4 | $166M | Buy |
1,972,919
+549,158
| +39% | +$46.2M | 0.01% | 1426 |
|
|
2017
Q3 | $131M | Buy |
1,423,761
+509,042
| +56% | +$46.9M | 0.01% | 1546 |
|
|
2017
Q2 | $73.4M | Buy |
914,719
+181,471
| +25% | +$14.6M | ﹤0.01% | 1830 |
|
|
2017
Q1 | $30.9M | Buy |
733,248
+219,837
| +43% | +$9.25M | ﹤0.01% | 2231 |
|
|
2016
Q4 | $16.5M | Buy |
513,411
+8,270
| +2% | +$266K | ﹤0.01% | 2505 |
|
|
2016
Q3 | $13.2M | Buy |
505,141
+5,858
| +1% | +$153K | ﹤0.01% | 2548 |
|
|
2016
Q2 | $11.6M | Buy |
499,283
+221,901
| +80% | +$5.14M | ﹤0.01% | 2583 |
|
|
2016
Q1 | $7.58M | Buy |
277,382
+24,797
| +10% | +$678K | ﹤0.01% | 2757 |
|
|
2015
Q4 | $7.19M | Buy |
252,585
+95,426
| +61% | +$2.71M | ﹤0.01% | 2817 |
|
|
2015
Q3 | $2.75M | Sell |
157,159
-20,319
| -11% | -$355K | ﹤0.01% | 3228 |
|
|
2015
Q2 | $3.2M | Buy |
177,478
+133,121
| +300% | +$2.4M | ﹤0.01% | 3211 |
|
|
2015
Q1 | $552K | Buy |
44,357
+8,650
| +24% | +$108K | ﹤0.01% | 3802 |
|
|
2014
Q4 | $420K | Buy |
+35,707
| New | +$420K | ﹤0.01% | 3779 |
|